Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus
Elisabeth McClymont, Marette Lee, Janet Raboud, et al.
Clinical Infectious Diseases (2018) Vol. 68, Iss. 5, pp. 788-794
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Estimates of the global burden of cervical cancer associated with HIV
Dominik Stelzle, Luana Fiengo Tanaka, Kuan Ken Lee, et al.
The Lancet Global Health (2020) Vol. 9, Iss. 2, pp. e161-e169
Open Access | Times Cited: 579
Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Melanie Thompson, Michael A. Horberg, Allison L. Agwu, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e3572-e3605
Open Access | Times Cited: 182
Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis
Lisa Staadegaard, Minttu M. Rönn, Nirali Soni, et al.
EClinicalMedicine (2022) Vol. 52, pp. 101585-101585
Open Access | Times Cited: 43
Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar
Soha Shawqi Albayat, Jesha Mundodan, Khalid A Elmardi, et al.
Women s Health (2024) Vol. 20
Open Access | Times Cited: 10
Unveiling the Therapeutic Horizon: HPV Vaccines and Their Impact on Cutaneous Diseases—A Comprehensive Review
Florica Șandru, Andreea-Maria Radu, Aida Petca, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 228-228
Open Access | Times Cited: 9
A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities
Michelle Shin, Liu Gui, Nelly Mugo, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 49
HPV vaccination in HIV infection
Charles Lacey
Papillomavirus Research (2019) Vol. 8, pp. 100174-100174
Open Access | Times Cited: 53
High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus
Joel M. Palefsky, Shelly Lensing, Marvin Belzer, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 8, pp. 1388-1396
Open Access | Times Cited: 29
Impact of Patient-physician Communication on Cervical Cancer Screening among Women aged 25-65
Ogochukwu Juliet Ezeigwe, Samuel Tundealao, Ogochukwu Ruth Abasilim, et al.
Journal of Medicine Surgery and Public Health (2025), pp. 100182-100182
Open Access
Prevention of HPV-associated cervical pathology in the 21st century
Alina Alexandrovna Grineva, Sabina Mubarizovna Ansarova, Julia Vyacheslavovna Basalova, et al.
Russian Medicine (2025)
Closed Access
Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis
Feixue Wei, Catharina J. Alberts, Andreia Albuquerque, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 11, pp. 1496-1504
Closed Access | Times Cited: 10
Coinfections in human papillomavirus associated cancers and prophylactic recommendations
Gayathri Ashok, Soumya Basu, P. Priyamvada, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 2
Closed Access | Times Cited: 3
Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV
Cecilia Losada, Hady Samaha, Erin M. Scherer, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1067-1067
Open Access | Times Cited: 8
HIV and skin infections
David Chandler, Stephen L. Walker
Clinics in Dermatology (2023) Vol. 42, Iss. 2, pp. 155-168
Closed Access | Times Cited: 6
A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus
Edison Johannes Mavundza, Alison B. Wiyeh, Phetole Walter Mahasha, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 2, pp. 426-435
Open Access | Times Cited: 16
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method
B Picard, Béatrix Cochand‐Priollet, Flore Rozenberg, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246338-e0246338
Open Access | Times Cited: 13
The state of the reproductive system of adolescent girls after vaccination against human papillomavirus using a quadrivalent vaccine
И.В. Караченцова, E. V. Sibirskaya, Mariya M. Fomina, et al.
Педиатрическая фармакология (2024) Vol. 21, Iss. 2, pp. 111-118
Open Access | Times Cited: 1
Effectiveness of ‘catch-up’ human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women
Michael J. Silverberg, Wendy A. Leyden, Jennifer O. Lam, et al.
Vaccine (2020) Vol. 38, Iss. 29, pp. 4520-4523
Open Access | Times Cited: 11
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study
Nicolas Folschweiller, Júlio César Teixeira, Smita Joshi, et al.
EClinicalMedicine (2020) Vol. 23, pp. 100353-100353
Open Access | Times Cited: 10
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop
Anne Schuind, Helen Rees, John T. Schiller, et al.
Preventive Medicine Reports (2023) Vol. 35, pp. 102331-102331
Open Access | Times Cited: 3
The effects of bivalent human papillomavirus (HPV) vaccination on high-risk anogenital HPV infection among sexually active female adolescents with and without perinatally acquired HIV
Pradthana Ounchanum, Pradthana Ounchanum, Jullapong Achalapong, et al.
Sexual Health (2023) Vol. 21, Iss. 1
Closed Access | Times Cited: 3
Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV
Elisabeth McClymont, Arianne Albert, Christine Wang, et al.
International Journal of STD & AIDS (2022) Vol. 33, Iss. 9, pp. 847-855
Open Access | Times Cited: 5
Human papillomavirus infection-related cancer risk for kidney transplant recipients during adult life can be reduced by vaccination during childhood and adolescence
Corina Nailescu, Marcia L. Shew
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 4
Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination
Elisabeth McClymont, Marette Lee, Janet Raboud, et al.
International Journal of Gynecology & Obstetrics (2020) Vol. 150, Iss. 1, pp. 108-115
Closed Access | Times Cited: 5
Low human papillomavirus vaccine uptake among women engaged in HIV care in Ontario, Canada
Catharine Chambers, Jennifer Gillis, Joanne Lindsay, et al.
Preventive Medicine (2022) Vol. 164, pp. 107246-107246
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top